| scholarly article | Q13442814 |
| P50 | author | Nicola Low | Q28152053 |
| Catherine L. Haggerty | Q55491915 | ||
| Brandie D Taylor | Q61162203 | ||
| Roberta B Ness | Q97311751 | ||
| P2093 | author name string | Sami L Gottlieb | |
| Fujie Xu | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Chlamydia trachomatis genital infection | Q11926640 |
| Chlamydia trachomatis | Q131065 | ||
| P304 | page(s) | S134-55 | |
| P577 | publication date | 2010-06-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Risk of sequelae after Chlamydia trachomatis genital infection in women | |
| P478 | volume | 201 Suppl 2 |
| Q30420776 | A 2-pyridone-amide inhibitor targets the glucose metabolism pathway of Chlamydia trachomatis |
| Q49359551 | A 30-Min Nucleic Acid Amplification Point-of-Care Test for Genital Chlamydia trachomatis Infection in Women: A Prospective, Multi-center Study of Diagnostic Accuracy |
| Q60302097 | A FACS-Based Genome-wide CRISPR Screen Reveals a Requirement for COPI in Chlamydia trachomatis Invasion |
| Q90028420 | A Recombinant Chlamydia trachomatis MOMP Vaccine Elicits Cross-serogroup Protection in Mice Against Vaginal Shedding and Infertility |
| Q61447736 | A Synthetic, Small, Sulfated Agent Is a Promising Inhibitor of . Infection |
| Q34955571 | A cohort study of Chlamydia trachomatis treatment failure in women: a study protocol |
| Q90184336 | A modified method for rapid quantification of Chlamydia muridarum using Fluorospot |
| Q55191052 | A pill for the partner via the chlamydia patient? Results from a mixed method study among sexual health care providers in the Netherlands. |
| Q84843216 | A possible mechanism for maintenance of the deleterious allele of human CASPASE-12 |
| Q83743487 | A randomised controlled trial using mobile advertising to promote safer sex and sun safety to young people |
| Q27315371 | Actin Recruitment to the Chlamydia Inclusion Is Spatiotemporally Regulated by a Mechanism That Requires Host and Bacterial Factors |
| Q34749353 | Activation of the NLRP3 inflammasome by vault nanoparticles expressing a chlamydial epitope. |
| Q37848123 | Adolescent STIs for primary care providers |
| Q37846961 | Advances in sampling and screening for chlamydia |
| Q37838639 | Aerosolized Non-viral Nucleic Acid Delivery in the Vaginal Tract of Pigs. |
| Q64264319 | Alternatively Activated Macrophages Are Host Cells for and Reverse Anti-chlamydial Classically Activated Macrophages |
| Q58758981 | An Adaptive -Specific IFN-γ-Producing CD4 T Cell Response Is Associated With Protection Against Chlamydia Reinfection in Women |
| Q59341047 | An Integrated Care Model With Implementation Roadmap to Improve Management and Control in India |
| Q36258765 | An observational study to evaluate three pilot programmes of retesting chlamydia-positive individuals within 6 months in the South West of England |
| Q38152063 | Anatomical causes of female infertility and their management. |
| Q37123840 | Animal Models for Studying Female Genital Tract Infection with Chlamydia trachomatis |
| Q24202140 | Antibiotics for treating genital chlamydia trachomatis infection in men and non-pregnant women |
| Q90721572 | Antibody Testing in Estimating Past Exposure to Chlamydia trachomatis in the Netherlands Chlamydia Cohort Study |
| Q35934198 | Apparently-Different Clearance Rates from Cohort Studies of Mycoplasma genitalium Are Consistent after Accounting for Incidence of Infection, Recurrent Infection, and Study Design |
| Q28488289 | Assessing a Potential Role of Host Pannexin 1 during Chlamydia trachomatis Infection |
| Q34035201 | Association of ethnicity with involuntary childlessness and perceived reasons for infertility: baseline data from the Study of Women’s Health Across the Nation (SWAN) |
| Q37851119 | Azithromycin Treatment Modulates the Extracellular Signal-Regulated Kinase Mediated Pathway and Inhibits Inflammatory Cytokines and Chemokines in Epithelial Cells from Infertile Women with Recurrent Chlamydia trachomatis Infection |
| Q35034215 | B cells enhance antigen-specific CD4 T cell priming and prevent bacteria dissemination following Chlamydia muridarum genital tract infection. |
| Q50117410 | Barriers and Facilitators of Partner Treatment of Chlamydia: A Qualitative Investigation with Prescribers and Community Pharmacists. |
| Q34788508 | Barriers to and facilitators of partner notification for chlamydia trachomatis among health care professionals. |
| Q38700835 | Barriers to sexually transmitted infection testing in New Zealand: a qualitative study |
| Q33924824 | Behavioral Decision Research Intervention Reduces Risky Sexual Behavior |
| Q64231141 | Biofilm in Genital Ecosystem: A Potential Risk Factor for Infection |
| Q37834023 | Burden of Chlamydia trachomatis in India: a systematic literature review |
| Q37228267 | CD4+ T cell expression of MyD88 is essential for normal resolution of Chlamydia muridarum genital tract infection |
| Q58733377 | Capsid protein Vp1 from chlamydiaphage φCPG1 effectively alleviates cytotoxicity induced by |
| Q37184041 | Characteristics and predictors of women who obtain rescreening for sexually transmitted infections using the www.iwantthekit.org screening programme |
| Q92126442 | Characterization of the Horizontal and Vertical Sexual Transmission of Chlamydia Genital Infections in a New Mouse Model |
| Q94374122 | Chlamydia (uncomplicated, genital) |
| Q41990919 | Chlamydia Infection Between Men and Women: A Cross-Sectional Study of Heterosexual Partnerships |
| Q37833925 | Chlamydia Trachomatis Seroprevalence and Ultrasound Diagnosed Uterine Fibroids in a Large Population of Young African-American Women |
| Q28655801 | Chlamydia among Australian Aboriginal and/or Torres Strait Islander people attending sexual health services, general practices and Aboriginal community controlled health services |
| Q37840313 | Chlamydia infection in individuals reporting contact with sexual partners with chlamydia: a cross-sectional study of sexual health clinic attendees |
| Q35169667 | Chlamydia muridarum infection associated host MicroRNAs in the murine genital tract and contribution to generation of host immune response. |
| Q34478752 | Chlamydia prevalence in the general population: is there a sex difference? a systematic review |
| Q56890718 | Chlamydia protein Pgp3 studied at high resolution in a new crystal form |
| Q37686714 | Chlamydia trachomatis Antibody Testing in Vaginal Mucosal Material versus Blood Samples of Women Attending a Fertility Clinic and an STI Clinic. |
| Q35536134 | Chlamydia trachomatis Infection Leads to Defined Alterations to the Lipid Droplet Proteome in Epithelial Cells |
| Q34785987 | Chlamydia trachomatis Infection: Screening and Management |
| Q92327777 | Chlamydia trachomatis Whole-Proteome Microarray Analysis of The Netherlands Chlamydia Cohort Study |
| Q21284727 | Chlamydia trachomatis and Genital Mycoplasmas: Pathogens with an Impact on Human Reproductive Health |
| Q90026195 | Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients |
| Q64101130 | Chlamydia trachomatis bacterial load, estimated by Cq values, in urogenital samples from men and women visiting the general practice, hospital or STI clinic |
| Q34291280 | Chlamydia trachomatis incidence and re-infection among young women--behavioural and microbiological characteristics |
| Q37408135 | Chlamydia trachomatis infection in HIV-infected women: need for screening by a sensitive and specific test |
| Q34469192 | Chlamydia trachomatis infection increases fallopian tube PROKR2 via TLR2 and NFκB activation resulting in a microenvironment predisposed to ectopic pregnancy |
| Q37834020 | Chlamydia trachomatis infection positivity rates determined by nucleic acid amplification test in patients of hospitals in the northeastern region of Ukraine. |
| Q44058797 | Chlamydia trachomatis regulates innate immune barrier integrity and mediates cytokine and antimicrobial responses in human uterine ECC-1 epithelial cells. |
| Q37850021 | Chlamydia trachomatis: The enemy of the Fallopian tube |
| Q40082116 | Chlamydia trachomatis: The persistent pathogen |
| Q34774853 | Chlamydia-specific CD4 T cell clones control Chlamydia muridarum replication in epithelial cells by nitric oxide-dependent and -independent mechanisms |
| Q36786613 | Chlamydial Intracellular Survival Strategies |
| Q36249378 | Clinical characteristics of genital chlamydia infection in pelvic inflammatory disease |
| Q36053573 | Comparable Genital Tract Infection, Pathology, and Immunity in Rhesus Macaques Inoculated with Wild-Type or Plasmid-Deficient Chlamydia trachomatis Serovar D |
| Q37586402 | Comparative study in infertile couples with and without Chlamydia trachomatis genital infection |
| Q37850562 | Comparing two definitions of ethnicity for identifying young persons at risk for chlamydia. |
| Q34068570 | Comparison of Genital Chlamydia trachomatis Infection Incidence Between Women With Infertility and Healthy Women in Iran Using PCR and Immunofluorescence Methods |
| Q36281332 | Comparison of the population excess fraction of Chlamydia trachomatis infection on pelvic inflammatory disease at 12-months in the presence and absence of chlamydia testing and treatment: Systematic review and retrospective cohort analysis |
| Q36329527 | Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular infection: a genome wide association study |
| Q46243938 | Converging epidemics of sexually transmitted infections and bacterial vaginosis in southern African female adolescents at risk of HIV. |
| Q41989587 | Cost-Benefit Analysis of a Chlamydia trachomatis Vaccine Program in Adolescent Girls in the United States |
| Q35167336 | Cost-effectiveness Analysis of Chlamydia trachomatis Screening Via Internet-based Self-collected Swabs Compared With Clinic-based Sample Collection |
| Q38698001 | Cost-effectiveness of microscopy of urethral smears for asymptomatic Mycoplasma genitalium urethritis in men in England. |
| Q37844591 | Cumulative risk of chlamydial infection among young women in Florida, 2000-2011. |
| Q37035293 | Current Chlamydia trachomatis Infection, A Major Cause of Infertility |
| Q49940948 | Current Research of Chlamydial Infection Diseases in China |
| Q36098129 | Design of the FemCure study: prospective multicentre study on the transmission of genital and extra-genital Chlamydia trachomatis infections in women receiving routine care |
| Q34092384 | Detection of pelvic inflammatory disease: development of an automated case-finding algorithm using administrative data |
| Q37845958 | Development status and future prospects for a vaccine against Chlamydia trachomatis infection |
| Q28066097 | Diagnostic Procedures to Detect Chlamydia trachomatis Infections |
| Q37844612 | Discordant prevalence of Chlamydia trachomatis in asymptomatic couples screened by two screening approaches |
| Q91605096 | Dissemination of Chlamydia from the reproductive tract to the gastro-intestinal tract occurs in stages and relies on Chlamydia transport by host cells |
| Q36042179 | Diversity of Cervicovaginal Cytokine Response to Incident Chlamydia trachomatis Infection Among a Prospective Cohort of Young Women |
| Q35041252 | Do Australian general practitioners believe practice nurses can take a role in chlamydia testing? A qualitative study of attitudes and opinions |
| Q35992860 | Does typing of Chlamydia trachomatis using housekeeping multilocus sequence typing reveal different sexual networks among heterosexuals and men who have sex with men? |
| Q36201930 | Domain Analyses Reveal That Chlamydia trachomatis CT694 Protein Belongs to the Membrane-localized Family of Type III Effector Proteins |
| Q54241824 | Double trouble: modelling the impact of low risk perception and high-risk sexual behaviour on chlamydia transmission |
| Q44059270 | Dynamic Energy Dependency of Chlamydia trachomatis on Host Cell Metabolism during Different Stages of Intracellular Growth: Possible role of Sodium -based energetics in Chlamydial ATP generation |
| Q43950731 | Early screening for Chlamydia trachomatis in young women for primary prevention of pelvic inflammatory disease (i-Predict): study protocol for a randomised controlled trial |
| Q37834350 | Effect of cold water-induced stress on immune response, pathology and fertility in mice during Chlamydia muridarum genital infection |
| Q36255304 | Effects of adrenomedullin on the expression of inflammatory cytokines and chemokines in oviducts from women with tubal ectopic pregnancy: an in-vitro experimental study |
| Q33982195 | Efficacy of interventions to increase the uptake of chlamydia screening in primary care: a systematic review |
| Q37849161 | Estimation of the Burden of Disease and Costs of Genital Chlamydia trachomatis Infection in Canada |
| Q64131885 | Evaluation and enumeration of online test providers for sexually transmitted infections, specifically chlamydia, in the Netherlands |
| Q37835624 | Examining Chlamydia trachomatis and Neisseria gonorrhoeae rates between 2010 and 2015: a population-based observational study |
| Q44059015 | Examining sociodemographic risk factors for Chlamydia trachomatis infection: a population-based cohort study |
| Q38635566 | Feasibility and acceptability of a web-based HIV/STD prevention program for adolescent girls targeting sexual communication skills |
| Q89592904 | Food Insecurity and Risk Indicators for Sexually Transmitted Infection Among Sexually Active Persons Aged 15-44, National Survey of Family Growth, 2011-2017 |
| Q30400694 | Forward genetic approaches in Chlamydia trachomatis |
| Q41712264 | Frequency and genotypes of Chlamydia trachomatis in patients attending the obstetrics and gynecology clinics in Jalisco, Mexico and correlation with sociodemographic, behavioral, and biological factors. |
| Q36231644 | Genital Chlamydia trachomatis Infection among Women of Reproductive Age Attending the Gynecology Clinic of Hawassa University Referral Hospital, Southern Ethiopia |
| Q34378357 | Genital Chlamydia trachomatis: an update |
| Q64244024 | Genital Infiltrations of CD4 and CD8 T Lymphocytes, IgA and IgG Plasma Cells and Intra-Mucosal Lymphoid Follicles Associate With Protection Against Genital Infection in Minipigs Intramuscularly Immunized With UV-Inactivated Bacteria Adjuvanted With C |
| Q36129347 | Genital tract lesions in sexually mature Göttingen minipigs during the initial stages of experimental vaginal infection with Chlamydia trachomatis serovar D. |
| Q35618489 | Global Multilocus Sequence Type Analysis of Chlamydia trachomatis Strains from 16 Countries |
| Q94488714 | Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019 |
| Q35147305 | Gonorrhea infection in women: prevalence, effects, screening, and management |
| Q52372482 | HLA-DQB1*06 is a risk marker for chlamydia reinfection in African American women. |
| Q37843753 | HPV and Chlamydia trachomatis co-detection in young asymptomatic women from high incidence area for cervical cancer. |
| Q43412944 | Has the Effectiveness of a Single Chlamydia Test in Preventing Pelvic Inflammatory Disease over 12 Months Been Overestimated? |
| Q58694783 | Healthcare-seeking behaviour of people with sexually transmitted infection symptoms attending a Sexual Health Clinic in New Zealand |
| Q34509538 | Heterogeneity in risk of pelvic inflammatory diseases after chlamydia infection: a population-based study in Manitoba, Canada. |
| Q92631724 | High Willingness to Participate in Partner Notification among Women Attending Reproductive Health and STI Clinics in Shenzhen, China: A Cross-Sectional Study |
| Q35189064 | High prevalence of rectal gonorrhea and Chlamydia infection in women attending a sexually transmitted disease clinic |
| Q57263217 | High rates of bacterial vaginosis and Chlamydia in a low-income, high-population-density community in Cape Town |
| Q35139777 | High-resolution genotyping of Chlamydia trachomatis by use of a novel multilocus typing DNA microarray. |
| Q57263221 | Hoë voorkomskoers van bakteriële vaginose en Chlamydia in ’n lae-inkomste, hoë-bevolkingsdigtheid gemeenskap in Kaapstad |
| Q90635035 | Immune response against Chlamydia trachomatis via toll-like receptors is negatively regulated by SIGIRR |
| Q35599675 | Impact and cost-effectiveness of chlamydia testing in Scotland: a mathematical modelling study. |
| Q34057486 | Improved plaque assay identifies a novel anti-Chlamydia ceramide derivative with altered intracellular localization |
| Q37850857 | Improving Chlamydia trachomatis retesting rates by mailed self-collection kit |
| Q34492625 | Improving chlamydia knowledge should lead to increased chlamydia testing among Australian general practitioners: a cross-sectional study of chlamydia testing uptake in general practice |
| Q35794583 | Incidence and predictors of annual chlamydia testing among 15-29 year olds attending Aboriginal primary health care services in New South Wales, Australia |
| Q33655242 | Incidence, diagnosis and management of tubal and nontubal ectopic pregnancies: a review |
| Q54237349 | Insights Into Vaginal Bacterial Communities and Metabolic Profiles of Chlamydia trachomatis Infection: Positioning Between Eubiosis and Dysbiosis. |
| Q28791052 | Integrating chemical mutagenesis and whole-genome sequencing as a platform for forward and reverse genetic analysis of Chlamydia |
| Q37837866 | Interventions to Improve Sexually Transmitted Disease Screening in Clinic-Based Settings. |
| Q37050178 | Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study. |
| Q64070724 | Learning what our target audiences think and do: extending segmentation to all four bases |
| Q43409833 | Low chlamydia testing uptake among young pregnant women in Australia highlights the need for national leadership in this area |
| Q61798513 | Marked reduction in fertility among African women with urogenital infections: A prospective cohort study |
| Q33675064 | Measurement of tissue azithromycin levels in self-collected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry (LC-MS/MS). |
| Q36434479 | Microbiological Characteristics of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in South African Women |
| Q101237382 | Modeling of variables in cellular infection reveals CXCL10 levels are regulated by human genetic variation and the Chlamydia-encoded CPAF protease |
| Q54988340 | Modelling the impact of correlations between condom use and sexual contact pattern on the dynamics of sexually transmitted infections. |
| Q28079643 | Molecular epidemiology and genotyping of Chlamydia trachomatis infection in a cohort of young asymptomatic sexually active women (18-25 years) in Milan, Italy |
| Q41995625 | Monitoring therapy success of urogenital Chlamydia trachomatis infections in women: A prospective observational cohort study |
| Q34743290 | Murine Chlamydia trachomatis Genital Infection Is Unaltered by Depletion of CD4+ T cells and Diminished Adaptive Immunity |
| Q99406968 | Murine Endometrial Organoids to Model Chlamydia Infection |
| Q44059220 | National Institute of Allergy and Infectious Diseases workshop report: "Chlamydia vaccines: The way forward". |
| Q35880483 | Natural Course of Chlamydia trachomatis Bacterial Load in the Time Interval between Screening and Treatment in Anogenital Samples. |
| Q37833756 | Neutrophils are Central to Antibody-Mediated Protection against Genital Chlamydia |
| Q34135999 | No indication for tissue tropism in urogenital and anorectal Chlamydia trachomatis infections using high-resolution multilocus sequence typing |
| Q44959785 | Non-medical use of prescription drugs and sexual risk behavior in young adults |
| Q60308262 | Non-standard treatment for uncomplicated urogenital infections: a systematic review |
| Q44059073 | Orchestration of the mammalian host cell glucose transporter proteins-1 and 3 by Chlamydia contributes to intracellular growth and infectivity |
| Q90427203 | Participation, retention, and associated factors of women in a prospective multicenter study on Chlamydia trachomatis infections (FemCure) |
| Q55400741 | Pathway-Wide Genetic Risks in Chlamydial Infections Overlap between Tissue Tropisms: A Genome-Wide Association Scan. |
| Q36592755 | Patient-Delivered Partner Treatment for Chlamydia, Gonorrhea, and Trichomonas Infection Among Pregnant and Postpartum Women in Kenya |
| Q37845477 | Pelvic inflammatory disease: identifying research gaps--proceedings of a workshop sponsored by Department of Health and Human Services/National Institutes of Health/National Institute of Allergy and Infectious Diseases, November 3-4, 2011. |
| Q26992247 | Pelvic inflammatory disease: improving awareness, prevention, and treatment |
| Q36931777 | Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections |
| Q60958289 | Persistence: A Survival Strategy to Evade Antimicrobial Effects and |
| Q44059383 | Physician Adherence to Sexually Transmitted Infection Screening Guidelines in an OB/GYN Teaching Clinic in Hawai'i |
| Q34146357 | Plasmid-cured Chlamydia caviae activates TLR2-dependent signaling and retains virulence in the guinea pig model of genital tract infection |
| Q35993319 | Population attributable fraction of pelvic inflammatory disease associated with chlamydia and gonorrhoea: a cross-sectional analysis of Australian sexual health clinic data |
| Q55362181 | Population-based study of chlamydial and gonococcal infections among women in Shenzhen, China: Implications for programme planning. |
| Q35212267 | Practice nurse chlamydia testing in Australian general practice: a qualitative study of benefits, barriers and facilitators |
| Q35973427 | Prevalence and risk factors of three curable sexually transmitted infections among women in Nairobi, Kenya |
| Q35868498 | Prevalence of 7 sexually transmitted organisms by multiplex real-time PCR in Fallopian tube specimens collected from Saudi women with and without ectopic pregnancy |
| Q36894797 | Prevalence of Chlamydia trachomatis infection in parturient women in Gipuzkoa, Northern Spain |
| Q54301840 | Prevalence of cases of Mycoplasma hominis, Mycoplasma genitalium, Ureaplasma urealyticum and Chlamydia trachomatis in women with no gynecologic complaints. |
| Q59332914 | Prevalence of chlamydia trachomatis infection among reproductive age women in sub Saharan Africa: a systematic review and meta-analysis |
| Q34966952 | Prevalence of genital Chlamydia trachomatis infection among young men and women in Spain |
| Q58112937 | Prevalence, risk factors, and medical costs of Chlamydia trachomatis infections in Shandong Province, China: a population-based, cross-sectional study |
| Q40515147 | ProjectHeartforGirls.com: Development of a Web-Based HIV/STD Prevention Program for Adolescent Girls Emphasizing Sexual Communication Skills. |
| Q37118386 | Proportion of Pelvic Inflammatory Disease Cases Caused by Chlamydia trachomatis: Consistent Picture From Different Methods |
| Q37835212 | Proportion of Tubal Factor Infertility due to Chlamydia: Finite Mixture Modeling of Serum Antibody Titers |
| Q35856824 | Protecting adolescents' right to seek treatment for sexually transmitted diseases without parental consent: the Arizona experience with Senate Bill 1309. |
| Q94923882 | Protection against a chlamydial respiratory challenge by a chimeric vaccine formulated with the Chlamydia muridarum major outer membrane protein variable domains using the Neisseria lactamica porin B as a scaffold |
| Q47194154 | Protective Effect of Vaccine Promoted Neutralizing Antibodies against the Intracellular Pathogen Chlamydia trachomatis |
| Q64058737 | Ptr/CTL0175 Is Required for the Efficient Recovery of From Stress Induced by Gamma-Interferon |
| Q35577557 | Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms |
| Q37837547 | Racial Differences in Receipt of Chlamydia Testing Among Medicaid-Insured Women in 2013. |
| Q50113978 | Racial/ethnic disparities in the lifetime risk of Chlamydia trachomatis diagnosis and adverse reproductive health outcomes among women in King County, Washington |
| Q35155626 | Rationale and design of REACT: a randomised controlled trial assessing the effectiveness of home-collection to increase chlamydia retesting and detect repeat positive tests |
| Q37850859 | Re-testing for chlamydia at sexual health services in Australia, 2004 - 08 |
| Q37846593 | Recognition and Treatment of Chlamydial Infections from Birth to Adolescence |
| Q64133298 | Relation between infection and pelvic inflammatory disease, ectopic pregnancy and tubal factor infertility in a Dutch cohort of women previously tested for chlamydia in a chlamydia screening trial |
| Q37835223 | Relationship between Chlamydia trachomatis and Mycoplasma genitalium infection and pregnancy rate and outcome in Iranian infertile couples |
| Q36211625 | Resolution of Chlamydia trachomatis Infection Is Associated with a Distinct T Cell Response Profile |
| Q34700425 | Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program |
| Q36197177 | Risk Factors associated with Paraurethral Duct Dilatation following Gonococcal Paraurethral Duct Infection in Men. |
| Q37055567 | Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model |
| Q43406315 | Risk of reproductive complications following chlamydia testing |
| Q37836148 | Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. |
| Q30575507 | Risk of self-reportedChlamydia trachomatisinfection by social and lifestyle factors – A study based on survey data from young adults in Stockholm, Sweden |
| Q58561051 | STI initiative: Improving testing for sexually transmitted infections in women |
| Q36872696 | STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection. |
| Q35666656 | Sample size considerations using mathematical models: an example with Chlamydia trachomatis infection and its sequelae pelvic inflammatory disease |
| Q37834944 | Sensing the enemy, containing the threat: cell-autonomous immunity to Chlamydia trachomatis |
| Q52775791 | Sexual Assertiveness Skills and Sexual Decision-Making in Adolescent Girls: Randomized Controlled Trial of an Online Program |
| Q37236771 | Sexual and testing behaviour associated with Chlamydia trachomatis infection: a cohort study in an STI clinic in Sweden |
| Q30239986 | Sexually transmitted diseases and infertility. |
| Q37833827 | Sexually transmitted infections: challenges ahead |
| Q85044753 | Standards of care provided by Early Pregnancy Assessment Units (EPAU): A UK-wide survey |
| Q90611008 | States with higher minimum wages have lower STI rates among women: Results of an ecological study of 66 US metropolitan areas, 2003-2015 |
| Q75838523 | Stimulated peripheral blood mononuclear cells from chlamydia-infected women release predominantly Th1-polarizing cytokines |
| Q28468521 | Structural and Biochemical Characterization of Chlamydia trachomatis DsbA Reveals a Cysteine-Rich and Weakly Oxidising Oxidoreductase |
| Q59340629 | Study protocol of the iMPaCT project: a longitudinal cohort study assessing psychological determinants, sexual behaviour and chlamydia (re)infections in heterosexual STI clinic visitors |
| Q37837221 | Subunit vaccines for the prevention of mucosal infection with Chlamydia trachomatis |
| Q52739442 | Temporal Trends in Population Level Impacts of Risk Factors for Sexually Transmitted Infections Among Men Who Have Sex with Men, Heterosexual Men, and Women: Disparities by Sexual Identity (1998-2013). |
| Q37836553 | Temporal proteomic profiling of Chlamydia trachomatis-infected HeLa-229 human cervical epithelial cells |
| Q35027443 | Testing-adjusted chlamydia notification trends in New South Wales, Australia, 2000 to 2010. |
| Q26827366 | The Epidemiology of Chlamydia trachomatis Organism Load During Genital Infection: A Systematic Review |
| Q36343688 | The Netherlands Chlamydia cohort study (NECCST) protocol to assess the risk of late complications following Chlamydia trachomatis infection in women. |
| Q92377291 | The Potential Role for Host Genetic Profiling in Screening for Chlamydia-Associated Tubal Factor Infertility (TFI)-New Perspectives |
| Q35417872 | The Role of Chlamydia trachomatis Polymorphic Membrane Proteins in Inflammation and Sequelae among Women with Pelvic Inflammatory Disease |
| Q35907811 | The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trial |
| Q35039253 | The chlamydia knowledge, awareness and testing practices of Australian general practitioners and practice nurses: survey findings from the Australian chlamydia control effectiveness pilot (ACCEPt). |
| Q27008375 | The molecular fingerprint of high grade serous ovarian cancer reflects its fallopian tube origin |
| Q34268058 | The prevalence of Chlamydia trachomatis infection in Australia: a systematic review and meta-analysis |
| Q90365082 | Time series analysis and forecasting of chlamydia trachomatis incidence using surveillance data from 2008 to 2019 in Shenzhen, China |
| Q41757475 | Time to pregnancy in subfertile women in German gynecological practices: analysis of a representative cohort of more than 60,000 patients |
| Q30543582 | To develop and measure the effectiveness and acceptability of a pharmacy-based chlamydia screening intervention in Australia |
| Q37844836 | Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines. |
| Q64136238 | Trends in Pelvic Inflammatory Disease Among American Indian and Alaska Native Women, Indian Health Service, 2001-2015 |
| Q34226318 | Tubal transport of gametes and embryos: a review of physiology and pathophysiology |
| Q33883182 | Understanding sexual healthcare seeking behaviour: why a broader research perspective is needed |
| Q36337305 | Unveiling New Molecular Factors Useful for Detection of Pelvic Inflammatory Disease due toChlamydia trachomatisInfection |
| Q37834874 | Update on Chlamydia trachomatis Vaccinology |
| Q54250859 | Urine metabolome in women with Chlamydia trachomatis infection. |
| Q29353677 | Urogenital Chlamydia trachomatis strain types, defined by high-resolution multilocus sequence typing, in relation to ethnicity and urogenital symptoms among a young screening population in Amsterdam, The Netherlands |
| Q33587275 | Using intervention mapping for the development of a targeted secure web-based outreach strategy named SafeFriend, for Chlamydia trachomatis testing in young people at risk |
| Q100751541 | Vaccination with the recombinant major outer membrane protein elicits long-term protection in mice against vaginal shedding and infertility following a Chlamydia muridarum genital challenge |
| Q35694671 | Variants in Toll-like Receptor 1 and 4 Genes Are Associated With Chlamydia trachomatis Among Women With Pelvic Inflammatory Disease |
| Q30465552 | Virulence determinants in the obligate intracellular pathogen Chlamydia trachomatis revealed by forward genetic approaches |
| Q50063991 | What Is the Optimal Time to Retest Patients With a Urogenital Chlamydia Infection? A Randomized Controlled Trial |
| Q55413855 | What influences university students to seek sexually transmitted infection testing?: A qualitative study in New Zealand. |
| Q40689139 | Why are men less tested for sexually transmitted infections in remote Australian Indigenous communities? A mixed-methods study. |
| Q34016064 | Why sexually transmitted infections tend to cause infertility: an evolutionary hypothesis |
Search more.